Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1186-1188

  Snyder, Ronald D ^a   Grdina, David J ^b  

^a DUPONT COMPANY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CLASTOGEN; CLINAFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ECHINOMYCIN; ETOPOSIDE; MITOMYCIN C; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RADIOPROTECTIVE AGENT;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CATALYSIS; CELL CULTURE; CELL CYCLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME INACTIVATION; GAMMA IRRADIATION; HAMSTER; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION;

ANIMALS; CATALYSIS; CELL CYCLE; CELL LINE; CRICETINAE; DNA TOPOISOMERASES, TYPE II; MERCAPTOETHYLAMINES; MICRONUCLEUS TESTS; RADIATION-PROTECTIVE AGENTS;

EID: 0034161975     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wasserman, T. Radioprotective effects of amifostine. Semin. Oncol., 26: 89-94, 1999.
2. Giambarresi, L., and Jacobs A. J. Radioprotectants. In: J. J. Conklin and R. I. Walker (eds.), Mililary Radiobiology, pp. 265-301. Orlando, FL: Academic Press, Inc., 1987.
3. Grdina, D. J., Nagy, B., Hill, C K., Wells, R. L., and Peraino, C. The radioprotector WR-1065 reduces radiation-induced mutagenesis at the hypoxanthine guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis (Lond.), 6: 929-931, 1985.
4. Schwartz, J. L., Giovanazzi, S. M., Karrison, T., Jones, C. and Grdina, D. J. 2-[(Aminopropyl)amino] ethanethiol mediated reductions in Co-60 γ ray and fission spectrum neutron induced chromosome damage in V79 cells. Radiat. Res., 113: 145-154, 1988.
5. Grdina, D. J., Constantinou, A., Shigematsu, N., and Murley, J. Inhibition of topoisomerase II α activity in CHO K1 cells by WR1065. Radiat. Res., 138: 44-52, 1994.
6. Sigdestad, C. B., Berquist, B., and Grdina, D. J. The effect of chemical protectors oncell cycle progression after gamma or neutron irradiation. Cell Prolif., 24: 271-280, 1991.
7. Murley, J. S., Constantinou, A., Kamath, N. S., and Grdina, D. J. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II α leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif., 30: 283-294, 1997.
8. Snyder, R. D. The use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Environ. Mol. Mutagen., in press, 2000.
9. Fenech, M., and Morley, A. A. Measurement of micronuclei in human lymphocytes, Mutat. Res., 147: 29-36, 1985.
10. Grdina, D. J., Shigematsu, N., Dale, P., Newton, G. L., and Aguilera, J. A. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-toxic and anti-mutagenic mechanisms of action. Carcinogenesis (Lond.), 16: 767-774, 1995.